ALLMedicine™ Dengue Center

Sep 23rd, 2021 - Dengue virus co-circulates globally as four serotypes (DENV1-4) that vary up to 40% at the amino acid level. Viral strains within a serotype further cluster into multiple genotypes. Eliciting a protective tetravalent neutralizing antibody response...

Sep 23rd, 2021 - The skin microbiota plays an essential role in the protection against pathogens. It is our skin microbiota that makes us smell different from each other, rendering us more or less attractive to mosquitoes. Mosquitoes exploit skin bacterial odours ...

Sep 23rd, 2021 - Half of the world's population is at risk of arthropod-borne virus (arbovirus) infections. Several arbovirus infections have been associated with Guillain-Barré syndrome (GBS). We investigated whether arboviruses are driving GBS beyond epidemic ph...

Sep 22nd, 2021 - The World Health Organization (WHO) has ranked dengue as one of the top ten threats to Global health in 2019. Sri Lanka faced a massive dengue epidemic in 2017, the largest outbreak in the country during the last three decades, consisting of 186,1...

Sep 22nd, 2021 - Oropouche fever is a zoonotic dengue-like syndrome caused by Oropouche virus. In August-September 2020, dengue-like syndrome developed in 41 patients in a remote rainforest village in French Guiana. By PCR or microneutralization, 23 (82.1%) of 28 ...

Jun 14th, 2019 - Dengue and Zika viruses are closely related mosquitoborne flaviviruses with similar transmission cycles, distribution throughout the tropics and subtropics, and disease manifestations including fever, rash, myalgia, and arthralgia. For patients wi...

Nov 26th, 2010 - Dengue fever is a virus infection that is spread by the Aedes aegypti mosquito and can cause severe disease especially in children. Dengue fever is a major problem in tropical and sub-tropical regions of the world. We invited dengue experts from a...

Jul 4th, 2008 - There is a pressing need for guidelines focused on the clinical evaluation of dengue vaccines in exposed populations, because Phase 1 and 2 clinical trials of dengue vaccines have begun, and Phase 3 field trials may be warranted soon. In response ...

Jun 14th, 2021 - A modestly titled new study released in the New England Journal of Medicine belies the extraordinary 77% protective efficacy reported for preventing dengue infections with Wolbachia-infected Aedes aegypti mosquitoes. A cluster-randomized clinical ...

Jun 10th, 2021 - NEW YORK (Reuters Health) - As cases of dengue fever make their way into the southern United States, with sometimes-fatal results, a new study in Indonesia offers evidence of an effective way to block the spread of the mosquito-borne infection. Th...

Jun 4th, 2021 - In a press release, Takeda announced that its vaccine candidate, TAK-003, reduced illnesses from dengue by 62% and prevented 83.6% of hospitalizations in its phase 3 TIDES trial, which enrolled more than 20,000 children and teens in Latin America ...

May 24th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. In a surprising study from the Amazon rainforest, Brazilian scientists found that symptomatic COVID-19 infections were twice as likely to occur in...

Nov 30th, 2020 - NEW YORK (Reuters Health) - The incidence of dengue appears to have dropped by 77% in areas of Yogyakarta City, Indonesia, that were treated with Wolbachia-infected mosquito eggs in a new cluster-randomized trial, according to new research. When m...